Provenienza dei contatti di primo grado di Matthias Klaften
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
amcure GmbH
 amcure GmbH BiotechnologyHealth Technology amcure GmbH develops active ingredients for the treatment of angiogenesis-related diseases. It offers a peptide based substance, that targets the tumor specific co-receptors. The company was founded by Matthias Klaften and Alexandra Matzke on December 14, 2011 and is headquartered in Eggenstein-Leopoldshafen, Germany.
3
| Holding Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Matthias Klaften tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
| Svizzera | 3 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Founder | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Klaus Dembowsky | 6 |
| Alexandra Matzke | 1 |
| Silvia Giordano | 1 |
- Borsa valori
- Insiders
- Matthias Klaften
- Connessioni Società
